BioAtla (BCAB) Capital Expenditures (2020 - 2023)
BioAtla's Capital Expenditures was $8,000 in Q4 2023, down 74.2% from $31,000 a year earlier and down 68.0% from the prior quarter.
Powered by 
Analysis
BioAtla (BCAB) Capital Expenditures (2020 - 2023) Analysis & Trends
For FY2023, Capital Expenditures at BioAtla came in at $98,000, down 63.4% from FY2022.
- Capital Expenditures shows a four-year compound annual growth rate of -49.5% (FY2019 to FY2023).
- In earlier years, Capital Expenditures was $268,000 in FY2022 (-71.0%), $924,000 in FY2021 (+56.6%), $590,000 in FY2020 (-60.9%) and $1.51 million in FY2019.
- The Q4 2023 figure marks the lowest quarterly Capital Expenditures in data going back to Q1 2020.
- Compared with a year earlier, Capital Expenditures has declined for three straight quarters, with an average decline of 6.9% over the last eight quarters.
- The best year-over-year quarter for Capital Expenditures over five years was Q1 2023 (growth of 400.0%); the worst was Q1 2022 (a decline of 98.0%).
- Per Business Quant data, BCAB's Capital Expenditures in the three quarters before Q4 2023 was $25,000 (Q3 2023), $15,000 (Q2 2023) and $50,000 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | BioAtla | 2.49 Mn | 2.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 31,000.00 |
| Sep 30, 2022 | 58,000.00 |
| Jun 30, 2022 | 169,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 89,000.00 |
| Sep 30, 2021 | 99,000.00 |
| Jun 30, 2021 | 235,000.00 |
| Mar 31, 2021 | 501,000.00 |
| Dec 31, 2020 | 395,000.00 |
| Sep 30, 2020 | 109,000.00 |
| Jun 30, 2020 | 66,000.00 |
| Mar 31, 2020 | 20,000.00 |
API Access
BioAtla Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();